Huntington's disease and cell therapies: Past, present, and future

7Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disease that is characterized by movement abnormalities, cognitive impairment, and abnormal behavior as well as sleep and weight problems. It is an autosomal dominant disorder caused by a mutation in the huntingtin gene on the short arm of chromosome 4, which results in the progressive degeneration of the basal ganglia (caudate, putamen, and globus pallidus), cerebral cortex, brainstem, thalamus, and hypothalamus. This chapter considers four avenues of research: (a) the restoration of neurogenesis as an endogenous cell therapy in HD, (b) fetal tissue transplantation, (c) stem cell transplantation, and finally (d) the use of endogenous trophic factors such as brain derived neurotrophic factor. © Springer Science+Business Media New York 2013.

Cite

CITATION STYLE

APA

Antoniades, C. A., & Watts, C. (2013). Huntington’s disease and cell therapies: Past, present, and future. Methods in Molecular Biology. Humana Press Inc. https://doi.org/10.1007/978-1-62703-411-1_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free